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The univector plasmid-fusion system, a method for rapid
construction of recombinant DNA without restriction enzymes
Qinghua Liu*†‡, Mamie Z. Li*†‡, Deborah Leibham*, David Cortez* 
and Stephen J. Elledge*†§
Background: Modern biological research is highly dependent upon
recombinant DNA technology. Conventional cloning methods are time-
consuming and lack uniformity. Thus, biological research is in great need of new
techniques to rapidly, systematically and uniformly manipulate the large sets of
genes currently available from genome projects. 
Results: We describe a series of new cloning methods that facilitate the rapid
and systematic construction of recombinant DNA molecules. The central
cloning method is named the univector plasmid-fusion system (UPS). The UPS
uses Cre–lox site-specific recombination to catalyze plasmid fusion between
the univector — a plasmid containing the gene of interest — and host vectors
containing regulatory information. Fusion events are genetically selected and
place the gene under the control of new regulatory elements. A second UPS-
related method allows for the precise transfer of coding sequences only from
the univector into a host vector. The UPS eliminates the need for restriction
enzymes, DNA ligases and many in vitro manipulations required for subcloning,
and allows for the rapid construction of multiple constructs for expression in
multiple organisms. We demonstrate that UPS can also be used to transfer
whole libraries into new vectors. Additional adaptations are described, including
directional PCR cloning and the generation of 3′ end gene fusions using
homologous recombination in Escherichia coli.
Conclusions: Together, these recombination-based cloning methods constitute
a new comprehensive approach for the rapid and efficient generation of
recombinant DNA that can be used for parallel processing of large gene sets, a
feature that will facilitate future genomic analysis.
Background
The discovery of restriction enzymes in the early 1970s
led to a revolution in the analysis of nucleic acids [1,2]. It
soon became apparent that the defined ends resulting
from the cleavage of DNA by such enzymes could be
joined by DNA ligases, thus allowing the recombination of
DNA molecules in vitro [3]. Together with the discovery
of autonomously replicating plasmids, this made possible
the isolation, propagation, and purification of individual
fragments of DNA. These discoveries ushered in the era
of molecular cloning in biological research. The ability to
recombine DNA fragments led not only to the cloning of
DNA fragments that encoded genes, but also to the
manipulation of genes in such a way as to alter their regu-
latory sequences [4]. The coding regions of genes could
be placed under the control of regulated promoters and
reintroduced into organisms to explore the consequences
of altered regulation. Coding regions could also be fused
to other coding regions to produce hybrid proteins with
unique properties that could be exploited for genetic or
biochemical purposes. 
The manipulation of genes has grown more sophisticated
as new techniques have emerged allowing finer and finer
alterations of sequences. The number of plasmid vectors
bearing unique properties for the analysis of genes has also
grown. For a routine analysis of a new gene it might be
desirable to express it in bacteria as a glutathione-S-trans-
ferase (GST) fusion protein or with a six-histidine (His6)
tag for purification and antibody production, to fuse it to
the DNA-binding domain of the yeast and bacterial tran-
scription factors Gal4 or LexA for yeast two-hybrid interac-
tion screening, to express it from the T7 promoter to allow
generation of a riboprobe or mRNA for in vitro transcription
and translation, and express it in baculovirus, all in the
course of a single study. One might also wish to express a
particular gene under the regulation of different promoters
in a variety of organisms or to mark it with different epitope
tags to facilitate subsequent biochemical or immunological
analysis. All of these manipulations consume significant
amounts of time and energy for two reasons. First, each of
the different vectors required for these studies were, for
the most part, developed independently and thus contain
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different sequences and restriction sites for the insertion of
the genes under study. Genes must therefore be individu-
ally tailored to adapt to each of these vectors. Secondly, the
DNA sequence of any given gene varies and can contain
internal restriction sites that make it incompatible with par-
ticular vectors, thereby complicating manipulation. The
advent of the polymerase chain reaction (PCR) has greatly
facilitated the alteration of gene sequences and the cre-
ation of compatible restriction sites for subcloning pur-
poses. The high error rate of thermostable polymerases
requires that the sequence of each PCR-derived DNA frag-
ment must be verified, however, and this clearly represents
a time-consuming process. 
The availability of whole genome sequences now presents
us with the opportunity to analyze large sets of genes for
both genetic and biochemical properties. The need to
perform parallel processing of large gene sets exponen-
tially amplifies the inherent defects associated with con-
ventional cloning methods. In this paper, we describe a
series of recombination-based approaches that signifi-
cantly reduce the time and effort involved in generating
recombinant DNA for gene analysis and cDNA library
construction. We have developed a method, termed the
univector plasmid-fusion system (UPS), whereby a gene
in a particular type of plasmid — the univector — can be
placed under the control of any of a variety of promoters or
fused in-frame to other coding sequences without the use
of restriction enzymes. This system, together with the
additional methods described herein, circumvents the
problems associated with conventional restriction-
enzyme-mediated cloning methods and provides a multi-
faceted approach for the rapid and efficient generation
and manipulation of recombinant DNA, thus making pos-
sible the parallel processing of whole genome sets of
coding sequences. 
Results
Development of the UPS 
UPS is based upon plasmid fusion using the Cre–lox
site-specific recombination system of bacteriophage P1.
The product of the cre gene is a site-specific recombi-
nase that catalyzes recombination between two 34 bp
loxP sequences and is involved in the resolution of P1
dimers generated by replication of circular lysogens [5].
Cre can function in vivo in several organisms including
bacteria, fungi and mammals and also functions in vitro
[6–8]. The scheme for UPS is shown in Figure 1a. The
pUNI plasmid is the univector into which the gene of
interest is inserted. The pHOST plasmid is the recipient
vector containing the appropriate transcriptional regula-
tory sequences that will eventually control the expres-
sion of the gene of interest in the designated host cells.
It may also carry translational initiation and additional
coding sequences for generating fusion proteins. A
recombinant expression construct is made through 
Cre–loxP-mediated site-specific recombination that
fuses pUNI and pHOST. 
The univector has a number of properties that facilitate its
use in this system: the maps for several different univector
plasmids are shown in Figure 1d. General features include
a loxP site placed directly adjacent to the 5′ end of the
polylinker for insertion of cDNAs. The loxP sequence has
a single open reading frame (ORF) that is in-frame with
the ATG of the NdeI and NcoI sites of the polylinker. This
facilitates the subsequent generation of protein fusions as
noted below. Following the polylinker are bacterial and
eukaryotic transcriptional terminators to facilitate 3′ end
formation of transcripts. The univector also has a condi-
tional origin of replication derived from the plasmid R6Kγ
that allows its propagation only in bacterial hosts express-
ing the pir gene (encoding the essential replication protein
pi) originally from R6Kγ [9]. The univector contains the
neo gene (which encodes kanamycin resistance, KnR) from
the transposable element Tn5 for selection in bacteria.
The pUNI20 univector contains additional site-specific
recombination sites, such as RS, which facilitate precise
ORF transfer (POT). The pUNI30 univector contains half
of a lacO site for directional PCR cloning (see below).
The pHOST vector features include the ColE1 origin of
replication, the bla gene (which encodes ampicillin resis-
tance, ApR) for propagation and selection in bacteria, a
loxP site for plasmid fusions and a specific promoter resid-
ing upstream of, and immediately adjacent to loxP. Host
vectors may also contain sequences responsible for propa-
gation, selection and maintenance in organisms other than
Escherichia coli. In pHOST vectors intended for protein
fusions, loxP is placed in the same reading frame as the
additional coding sequence. In order for all UPS-derived
protein fusions to be automatically in-frame, the target
gene must be cloned into the univector in-frame with the
loxP ORF (Figure 1d).
The UPS reaction can be carried out both in vitro or in
vivo in the presence of Cre recombinase. The reaction
results in the fusion of a pUNI plasmid with a pHOST
plasmid via the loxP site to create a recombinant plasmid,
thereby placing the target gene under the control of the
regulatory sequences on the host vector. Selection for the
recombination products of UPS is achieved by selecting
for kanamycin resistance after transformation into a pir–
strain (typical E. coli strains are pir–) because the neo gene
in pUNI can only be propagated when covalently linked
to an origin of replication (oriColE1) in pHOST that is func-
tional in a pir– background. 
Generation of a functional GST–Cre fusion protein
To simplify Cre purification, a plasmid, pQL123, express-
ing a GST–Cre fusion protein was constructed. The
expression of GST–Cre was highly induced in E. coli in
Research Paper  Cloning using site-specific recombination Liu et al.    1301
the presence of isopropyl β-D-thiogalactoside (IPTG) 
and was purified to near homogeneity with
glutathione–Sepharose beads [10] (Figure 1b). GST–Cre
retained high recombinase activity as measured by UPS.
The efficiency of this reaction reached up to 16.8%
(Figure 1c), similar to that for native Cre [6]. The effi-
ciency of GST–Cre-mediated recombination was exam-
ined in a second reaction which involved the production
of an GST-tagged version of the Saccharomyces cerevisiae
ubiquitin–ligase protein Skp1 (shown in Figure 2a) [11].
Recombinant plasmids isolated from KnR transformants
were shown by restriction analysis to be correct fusion
products of the univector and the host vector via the loxP
sites. In this case, 10 out of 12 KnR transformants con-
tained the desired fusion of the two plasmids (Figure 2b).
Two of the transformants (Figure 2b, lanes 8,10) con-
tained two copies of pHOST fused to one copy of the
pUNI construct: it should be noted that these fusion
products also have a correct fusion junction and are fully
functional for most needs. This method is highly efficient
and typically requires analysis of only one or two clones to
identify the desired construct.
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(a) A schematic representation of the UPS cloning strategy. Cre
catalyzes site-specific recombination between loxP sites, generating
plasmid fusion between pUNI and pHOST. This results in a fusion
plasmid in which the gene of interest from pUNI is placed under the
control of pHOST regulatory elements. (b) Expression and purification
of GST–Cre. Lane 1 contains 100 µg total cell extract from GST–Cre-
expressing BL21/pQL123 cells grown in the presence of IPTG. Lane 2
shows GST–Cre (2 µg) after a single-step purification with glutathione
beads. (c) Recombinase activity of GST–Cre. UPS reactions were
carried out with different amounts of GST–Cre as described in
Materials and methods. The efficiency of the UPS reactions is shown
as the ratio of total KnR transformants to total ApR transformants.
(d) Maps of pUNI10, pUNI20 and pUNI30. Nucleotide positions of
restriction sites are shown with non-unique sites in bold. Functional
sequences are shown as filled boxes and are labeled inside the circle.
Below each map is the polylinker sequence displayed as codons in-
frame with the ORF of loxP.
Testing expression constructs made by UPS 
A series of expression plasmids were made by UPS and
tested for expression in several contexts. The SKP1 ORF
in pUNI10 was fused to the pHB2-GST recipient vector
by UPS to create a bacterial GST–lox–Skp1 fusion
protein expressed from the E. coli tac promoter
(Figure 2b). A similar GST–Skp1 expression plasmid
lacking loxP (pCB149) made by conventional cloning was
used as a control. Approximately equal amounts of the
two fusion proteins were expressed (Figure 2c,d), indi-
cating that the presence of loxP did not significantly
affect either the transcription or the translation of the
fusion protein.
The loxP sequence contains a potential 13 bp stem-loop
structure, and secondary structures formed within the 5′
untranslated region (UTR) of an mRNA can potentially
interfere with the initiation of translation in eukaryotic cells
[12]. To test the effects of loxP sites upon translation, we
made a series of lox sites containing mutations designed to
reduce the stability of the stem-loop. These, together with
a control site lacking the stem-loop, loxS (ATAACTCCG-
TATAGCATACATTTAACTTCGTATT; mutations in
bold), were placed between the GAL1 promoter and a lacZ
reporter gene and β-galactosidase expression was measured
using S.cerevisiae Y80 as host. The loxP sequence reduced
β-galactosidase expression fourfold relative to loxS. In 
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Figure 2
Expression of UPS-derived constructs in
multiple systems. (a) A schematic
representation of the generation of epitope-
tagged expression constructs by UPS. (b) A
PstI restriction analysis of the UPS-derived
GST–lox–Skp1 recombinant plasmids.
Plasmid DNA from 12 independent KnR
transformants was digested with PstI and the
digestion products were separated on a 1%
agarose gel and visualized by ethidium bromide
staining (lanes 1–12). The parental plasmids,
pUNI10-SKP1 (pQL130; lane P1), and pHB2-
GST (lane P2), each contain a single PstI
restriction site and upon cleavage generate a
2.8 kb or 5.0 kb fragment, respectively. The
correct fusion product produces two bands of
2.0 kb and 5.8 kb. (c,d) Expression levels of
GST–Skp1 constructs generated by UPS or
conventional methods. Proteins prepared from
a conventionally-derived GST–Skp1 plasmid
(lanes 1,2) and three independent UPS-
derived GST–lox–Skp1 plasmids (lanes 3–8)
were separated by SDS–PAGE and
(c) stained with Coomassie blue or
(d) immunoblotted with anti-Skp1 antibodies.
The arrow indicates the position of GST–Skp1,
whereas the arrowhead indicates the position
of slightly larger GST–lox–Skp1 protein. The
asterisk denotes a degradation product. (e)
Expression of UPS-derived constructs in S.
cerevisiae and comparison between loxP- and
loxH-containing constructs. Protein extracts
were prepared using a standard protocol.
Vector alone (pQL138; lane 1), conventionally-
derived control GAL:MYC3–RNR4 (pQL222)
lacking a lox site (lane 2), UPS-derived
GAL:MYC3–RNR4 constructs containing loxP
(lane 3) or loxH (lane 4); vector alone
(pHY314-MYC3; lane 5), or GAL:MYC3-
RAD53 (pUNI-RAD53::pHY314-MYC3) made
by UPS (lane 6). Western blots were probed
with anti-Myc antibodies for expression and
anti-Skp1 antibodies for a loading control in
lanes 1–4. (f) Expression of UPS-derived
baculovirus constructs in insect cells. The
pUNI-RAD53 plasmid was fused by UPS to
pHI100-GST, pHI100-MYC3 or pHI100-HA3
to generate GST–Rad53, Myc3–Rad53 and
HA3–Rad53, respectively. These recombinant
plasmids were used to make baculovirus. Total
cell extracts are prepared from 2 × 106 cells
infected with baculovirus derived from
GST–Rad53 constructs made by conventional
cloning (lane 1) or UPS (lane 2), no virus
(lane 3), Myc3–Rad53 (lane 4), no virus
(lane 5) and HA3–Rad53 (lane 6). Gels were
Coomassie stained (lanes 1,2) or
immunoblotted with anti-Myc (lanes 3,4) or
anti-HA antibodies (lanes 5,6). (g) Expression
of UPS-derived constructs in mammalian cells.
Hela cells were transfected by the calcium
phosphate method with the CMV expression
vectors pHM200-HA3 or pHM200-HA3–F3,
expressing an HA-tagged F-box protein. Whole
cell lysates were subjected to immunoblotting
with anti-HA antibodies.
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contrast, various loxP mutants with decreased stem-loop
stability tended to result in better expression of β-galactosi-
dase. One mutant, loxH (ATTACCTCATATAGCATA-
CATTATACGAAGTTAT; mutations in bold), failed to
display inhibitory effects when compared with loxS (data
not shown). The effects of loxH were further tested by
using it to place the gene encoding the ribonucleotide
reductase Rnr4 protein tagged with three copies of the Myc
epitope, MYC3–RNR4, under the control of the GAL1 pro-
moter; loxH showed improved translational ability relative
to loxP (Figure 2e, compare lanes 2–4). It should be noted
that the control lacking a lox site in Figure 2e has a differ-
ent spacing and is not completely isogenic for the purposes
of comparing translational efficiency of loxH. When paired
with loxP, loxH also retained 25% of the wild-type recombi-
national efficiency (data not shown) which is well within
the useful range for UPS-mediated plasmid construction.
We recommend that loxH be used in recipient vectors
intended for transcriptional fusions to maximize expres-
sion, whereas loxP should be used for all other applications
because of its higher recombination efficiency. 
Multiple genes have been tested using UPS and
expressed in several different organisms. In addition to
GST–Skp1 expression in bacteria, Myc3-tagged versions
of Rnr4 and the checkpoint protein Rad53 have been
expressed in S. cerevisiae (Figure 2e). Furthermore, many
baculovirus expression constructs have been made by
UPS and tested (our unpublished observations) and
shown here are GST–Rad53, Myc3–Rad53, and
HA3–Rad53 (Rad53 tagged at the amino terminus with
three copies of the hemagglutinin (HA) tag; Figure 2f).
The UPS-derived construct encoding GST–Rad53
expressed it to the same level as GST–Rad53 generated
by conventional methods (Figure 2f, compare lanes 1 and
2). In mammals we have demonstrated expression of a
HA3-tagged F-box protein under the control of the
cytomegalovirus (CMV) promoter in Hela cells
(Figure 2g). Over 200 UPS-derived constructs show
expression success rates indistinguishable from those of
conventional cloning methods for all genes and all organ-
isms tested thus far. 
In vivo UPS 
Cre–loxP-mediated plasmid fusion can also occur in vivo.
Ideally, it would be desirable to have Cre present only tran-
siently to catalyze the initial fusion event, then absent to
allow the stable propagation of the recombinant products.
We therefore explored UPS in vivo in the E. coli strain
BUN13 which expresses an integrated cre gene under the
control of the lac promoter and in a second strain, BUN14,
carrying lac–cre on a plasmid, pQL269, with a temperature-
sensitive origin of replication derived from pSC101. Experi-
ments using BUN13 and co-transformation of pUNI10 and
pQL103, a recipient plasmid, showed that the UPS reaction
occurs efficiently in vivo but many colonies had a mixture of
plasmids that required retransformation into a strain that did
not express cre to allow for stabilization (data not shown).
Results with BUN14 were better, however. Competent
cells were prepared from BUN14 cells grown at 42°C to
allow both Cre production and loss of pQL269. Co-tranfor-
mation of pUNI10 and pQL103 into these cells followed by
kanamycin selection at 42°C revealed that 25% of transfor-
mants contained the desired single pUNI10–pQL103 co-
integrant. These experiments demonstrate that UPS can be
performed in vivo and provide an alternative to the in vitro
reaction when GST–Cre is not available. 
UPS can be used for precise ORF transfer (POT)
UPS-derived constructs are suitable for the vast majority
of expression needs. In rare cases, however, where the size
of the recombinant molecule is limiting, for example retro-
viruses, it might be desirable to transfer only the gene of
interest and not the remaining 2 kb of the univector. To
accomplish this, we devised the POT strategy. POT uses
a second recombination event catalyzed by the R recombi-
nase [13] that allows the resolution of a UPS-generated
two-plasmid fusion as shown in Figure 3a. We placed an R
recombination site, RS, after the cloning site in pUNI20
such that any gene inserted into pUNI20 would be
flanked by loxP and RS. Recipient vectors must also
contain loxP and RS elements in the same order. POT can
be carried out in two sequential steps or in one step. For
the two-step method, the initial fusion event is achieved
by UPS. The second step can be catalyzed either in vitro
by incubation with purified R recombinase [13], or in vivo
by transformation into a strain (BUN15) expressing the R
recombinase under the control of the tac promoter on a
temperature-sensitive replication plasmid (pML66) which
is lost when cells are plated at 42°C. R-mediated recombi-
nation can achieve 30% efficiency in vitro and 15% effi-
ciency in vivo (data not shown).
POT can be achieved efficiently in a single step with a
seletion through the use of a counterselectable marker
that is placed between loxP and RS on pHOST. For this
purpose we have used the ΦX E gene which is toxic
when expressed in E. coli unless the host cell lacks the
slyD gene encoding a cis-trans peptidyl-prolyl isomerase
[14]. A two-hybrid recipient vector pAS2-E was con-
structed from pAS2 [15] that contains (from 5′ to 3′) loxP,
tac-E and RS. After a UPS reaction between
pUNI20-SKP1 and pAS2-E, the reaction mixture was
transformed directly into BUN15 cells (pir– slyD+) in the
presence of IPTG to induce E expression selecting for
ampicillin resistance. Due to the toxicity of E, the only
ApR transformants surviving would be those containing
the recombinants that have undergone POT. The toxic
ΦX E gene along with the univector backbone will be
eliminated by the R-dependent site-specific recombina-
tion, resulting in the replacement of E on pAS2-E by
SKP1. As shown in Figure 3b, 100% (20 out of 20) of ApR
transformants contained the desired recombinant prod-
ucts as determined by restriction analysis with PvuII.
Generation of 3¢ gene fusions using homologous
recombination in E. coli
Although UPS greatly facilitates the generation of fusion
proteins at the amino terminus of the protein of interest, it
is often necessary to modify proteins at the carboxyl termi-
nus. To facilitate this class of modification, we have taken
advantage of the endogenous homologous recombination
system of E. coli. It has been previously shown that E. coli
strains mutant for the recombination genes recBC and sbc
[16] or strains mutant for recD [17] can take up linear DNA
and recombine it into the E. coli chromosome or resident
plasmids. We therefore generated BUN10, a recBCsbcAhsdR
strain expressing pir-116. The hsdR mutation is needed to
prevent restriction of unmethylated PCR-amplified DNA
by the endogenous E. coli restriction enzyme encoded by
hsdR. We tested this by tagging the SKP1 gene in pUNI at
its carboxyl terminus with the Myc3 tag. An ApR pUNI
derivative containing a MYC3 epitope tag followed by a
stop codon, pML74, was used as template DNA for PCR
amplification. Primer A (71 nt) contains at its 5′ end 51 nt
which correspond to the last 51 nt of the SKP1 ORF
(excluding the stop codon) and at its 3′ end the first 20 nt
of the DNA encoding the Myc3 tag in-frame with the SKP1
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Precise ORF transfer (POT) and carboxy-terminal epitope-tagging of
proteins using homologous recombination in E. coli. (a) A schematic
representation of POT. The initial fusion event of a two-step POT
reaction is catalyzed by UPS followed by a second resolution reaction
catalyzed by R-mediated recombination that eliminates both the toxic ΦX
E gene and the univector backbone. The second step can be performed
in vitro with purified R recombinase or in vivo by transformation into
BUN15 which conditionally expresses R. POT can also be achieved in a
single step by directly transforming the UPS reaction mixture into BUN15
(see text). (b) A PvuII restriction analysis of the recombinant plasmids
generated by one-step POT between pUNI20-SKP1 (pML73) and
pAS2-E. P1 and P2 refer to pUNI20-SKP1 and pAS2-E, respectively. 
I represents the intermediate generated by plasmid fusion. The analysis
of 10 ApR transformants is shown in lanes 1–10 and a new 800 bp band
is indicative of POT and is indicated by an arrowhead. (c) A diagram
showing 3′ end gene fusion via homologous recombination in E. coli.
Primers A and B (see Materials and methods) are used to amplify the
MYC3 tag from pML74, generating a PCR fragment containing MYC3
flanked by 51 bp homology to the 3′ end of the SKP1 ORF and 367 bp
homology to the univector (see text). The blunt-ended PCR product was
co-transformed into BUN10 with pUNI20-SKP1 (pML73) DNA linearized
3′ to SKP1. Homologous recombination between two linear DNA
fragments result in a circular plasmid containing SKP1 fused to MYC3 at
its carboxyl terminus. (d) Expression of Skp1–Myc3 generated by
homologous recombination. Two pUNI-SKP1–MYC3 plasmids generated
in (c) were fused to pHY326 by UPS to generate GAL:SKP1–MYC3
plasmids and proteins expressed from these in the yeast strain Y80 in
the presence of glucose or galactose were detected by immunoblotting
with anti-Skp1 and anti-Myc antibodies.
ORF. Primer B (22 nt) recognizes a site on pML74
common to all pUNI vectors that begins 367 bp from the
MYC3 region. Thus, PCR-amplified DNA will contain a
MYC3 tag flanked by 51 bp homology to the SKP1 gene
and 367 bp homology to the univector. This PCR frag-
ment, together with BamHI–SacI-linearized pUNI20-
SKP1 DNA, was co-transformed into BUN10 cells and
KnR transformants were selected. Homologous recombina-
tion at the carboxyl terminus of the SKP1 gene to generate
a SKP1–MYC3 fusion occurred in 95% of KnR transformants
(data not shown). This pUNI-SKP1–MYC3 construct was
fused to pHY326 to generate a 2µ URA3 GAL:SKP1–MYC3
expression construct. Expression of the fusion protein
could be detected in S. cerevisiae (Figure 3d). This demon-
strates that homologous recombination in E. coli can be
used to alter the sequence of genes at the 3′ end using
PCR-derived material. 
Methods that facilitate gene transfer into the univector and
other plasmids
Subcloning DNA into vectors is limited by the restriction
sites available. When cloning blunt-ended DNA molecules
such as those generated by thermostable polymerases, it is
desirable to have a way of identifying recombinant mole-
cules. This is of significant interest to us because the initial
cloning of genes into pUNI will often use PCR-amplified
material. To facilitate this process, we have developed a
method for directional cloning into pUNI derivatives that
relies upon the generation of a lac operator site upon liga-
tion. Plasmid and phage carrying the binding site for the lac
repressor, lacO, could induce the expression of the endoge-
nous lacZ gene by titrating out a limiting number of repres-
sor proteins [18–20] (Figure 4a). We took advantage of this
observation by placing the 3′ half of a modified lacO site in
pUNI30 (Figure 4b). This lacO derivative is a symmetrical
20 bp site with a Eco47III restriction site at the center.
PCR primers were made to amplify the bla gene. To the 5′
end of the 3′ primer, an extra 10 bp was added that corre-
sponds to the 5′ half of the symmetrical lacO site. The
PCR-amplified DNA was ligated to Eco47III-cleaved
pUNI30, transformed into BUN10 (pir-116 lac+), and
selected on plates containing kanamycin and X-gal. Plas-
mids containing bla in the correct orientation were identi-
fied by their dark blue color (Figure 4c): 11 out of 12 dark
blue colonies contained full-length bla in the correct orien-
tation (data not shown). This method works best when the
PCR primers used are phosphorylated. If Taq polymerase
is used, it is necessary to briefly treat the material with T4
DNA polymerase and dNTPs to remove 3′ overhangs.
Library transfer using UPS
One of the most significant advances made possible by the
UPS method is the generation of libraries in the univector
that can then be transferred into other specialized vectors,
essentially turning one library into many libraries. We
tested this possibility by making a randomly sheared S.
cerevisiae genomic library in pUNI10 using the XhoI-
adaptor strategy [21]. This library had 5 × 105 recombi-
nants with 80% of inserts ranging from 3 to 8 kb. This
library was fused using UPS to a 2µ URA3 plasmid
pRS426-lox and 2 × 107 KnR transformants were recov-
ered. We demonstrated that the converted library main-
tained its representation by examining the presence of 42
different ORFs by PCR. Both the pre-UPS and post-UPS
libraries contained all 42 ORFs (data not shown). This
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Figure 4
Directional cloning of PCR fragments by reconstituting a functional lac
operator. (a) A diagram illustrating induction of the endogenous lacZ
gene by titration of the lac repressor by a high copy number plasmid
containing lacO sites. Normally, the endogenous lacZ gene is
repressed by lac repressors bound to its lacO sites (left). When lacO
sites are present on a high copy number plasmid, however, the lac
repressor molecules are bound by plasmids (right), thereby
derepressing the transcription of lacZ. (b) A representation of
directional PCR cloning by lacO reconstitution. Primers A (5′) and
B (3′) are used to amplify the gene of interest. The 5′ end of primer B
contains a half lacO site which subsequently becomes the 3′ end of
the PCR fragment as shown. After ligating the PCR fragment into
Eco47III-linearized pUNI30 that contains the other half of lacO, an
intact lacO site is reconstituted and, in lac+ cells, results in induction of
endogenous β-galactosidase and blue color in the presence of X-gal.
(c) Photos of colonies from a ligation as in (b) transformed into BUN10
cells (lac+) and plated on LB plates containing kanamycin and X-gal.
The reconstituted lacO sites result in blue colonies (arrows) due to
induction of the endogenous lacZ. Reclosure of the vector without
insert or insertion of the PCR fragment in the incorrect orientation
results in white or pale blue colonies.
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UPS-derived 2µ yeast genomic library was used to comp-
lement a temperature-sensitive mutation in the F-box
protein Cdc4, cdc4-1 [22], at the non-permissive tempera-
ture (34°C). Three classes of suppressors were recovered,
CDC4, SKP1 and the mitotic cyclin CLB3 (data not
shown). SKP1 and CLB4, a cyclin closely related to CLB3,
had been previously shown to suppress cdc4-1 mutants
when overexpressed from the GAL promoter [11,22].
These experiments demonstrate the feasibility of library
transfer using UPS. In cases where a cDNA expression
library is created, such as for the two-hybrid system, once
positive clones have been isolated they can rapidly be con-
verted back into simple univector clones by Cre recombi-
nation in vivo. These univector clones can then be fused
with any pHOST by UPS to generate expression con-
structs for future analytical needs. 
Discussion
Unlike the conventional ‘cut-and-paste’ strategy of restric-
tion-enzyme-based methods, recombinant DNA assem-
bled by UPS is achieved by plasmid fusion through
site-specific recombination. UPS can be used to fuse a
coding region of interest either with a specific promoter to
gain novel transcriptional regulation, or with another
coding sequence to produce a fusion protein with new
properties. UPS eliminates the use of restriction enzymes
and DNA ligase: instead, these functions are both carried
out simultaneously by a single enzyme, Cre. This relieves
the constraints on cloning vectors with respect to DNA
sequence and size because the UPS reaction is indepen-
dent of vector size or sequence. Furthermore, the time-
consuming processes inherent in conventional cloning,
such as the identification of a suitable vector, designing a
cloning strategy, restriction endonuclease digestion,
agarose gel electrophoresis, isolation of DNA fragments,
and the ligation reaction, is shortened to a 20 minute UPS
reaction. Due to the uniformity and simplicity of UPS,
dozens of constructs can be made simultaneously by
simply using different recipient vectors. In addition,
unlike restriction enzymes and DNA ligases, GST–Cre
can be made inexpensively in large quantities. These fea-
tures will save investigators significant amounts of time
and expense. 
The univector has a number of features that make it espe-
cially useful for the UPS method. It is small, adding only a
minimal amount of DNA to a construct, and brings in its
own transcriptional termination signals, which simplifies
the recipient vector construction. Its conditional origin of
replication can exist at two different copy numbers
depending on the pir allele present in the bacterial strain
used for propagation [9]. The wild-type pir+ allele confers
a low copy number, 15 copies per cell, while the pir-116
allele confers a high copy number, 250 copies per cell.
This property may be useful when potentially toxic genes
are manipulated. Furthermore, the only promoter present
in the univector is that driving the neo gene, which is tran-
scribed in the opposite direction from cDNAs cloned into
the univector. This lessens the chances that a toxic gene
will be expressed.
While at present we have generated approximately 40
pHOST vectors (Q.L., S.J.E. and J.W. Harper, unpub-
lished), we are in the process of generating prototype
recipient vectors for all general expression needs. We have
successfully tested bacterial GST, yeast GAL1 and mam-
malian CMV expression vectors and many baculovirus
expression vectors. In each case, expression was at or near
the levels achieved by conventional cloning methods. The
generation of pHOST vectors is simple, requiring only the
insertion of an oligonucleotide linker containing a loxP or
loxH site into pre-existing vectors. 
We have developed additional methods to facilitate gene
manipulation by UPS. POT employs both the Cre–lox and
R–RS site-specific recombination to precisely transfer an
ORF from pUNI to pHOST. We have devised a simple
directional PCR cloning method to facilitate the introduc-
tion of genes into the univector based on the reconstitu-
tion of a lacO site upon ligation. Finally, we have solved
the problem of generating 3′ end gene fusions using UPS
by taking advantage of endogenous homologous recombi-
nation in E. coli. These methods make gene manipulaion
using UPS a facile process. 
Future uses of the UPS
The high efficiency of the in vitro UPS reaction coupled
with the highly efficient electroporation method of bacter-
ial transformation makes possible the conversion of whole
cDNA libraries constructed in the univector into expres-
sion libraries in a different vector without loss of represen-
tation, as we demonstrated with a yeast genomic library.
Thus, a single library could be converted into a number of
different expression libraries and will no longer need to be
remade from scratch when needed in a different context.
Clones isolated from these libraries will be easily con-
verted back into simple univector plasmids compatible
with other pHOST vectors for future analysis. UPS is
compatible with the λYES series of lambda cloning
vectors which use Cre–lox recombination to convert phage
libraries into plasmid libraries [21] and which are capable
of making extremely large cDNA libraries (>108 recombi-
nants per 100 ng of cDNA) and, unlike plasmid libraries,
can be propagated with minimal loss of representation. 
One promising future application of the UPS method is
the manipulation of whole genome sets of coding regions.
For organisms for which the genomes have been
sequenced, a complete set of identified ORFs can be con-
structed in the univector to make a ‘Unigene’ array ready
for transfer into any expression system. Furthermore, the
simplicity and uniformity of the UPS reaction makes it
readily amenable to automation for systematic conversion
of arrayed clones. This will greatly expedite the functional
characterization of whole genomes and help further the
progression of genome projects into proteome projects.
Conclusions
In this study, we have described a novel and broadly
applicable approach to the generation of recombinant
DNA. This new series of recombination-based cloning
technologies overcomes many of the defects associated
with the currently available conventional cloning
methods. Together, these methods constitute a compre-
hesive strategy for the rapid and systematic generation
and manipulation of recombinant DNA molecules without
the use of restriction enzymes. Furthermore, these recom-
bination-based technologies open new avenues for the
systematic manipulation and processing of large gene sets
in parallel, a feature that is essential for future functional
genomic research. 
Materials and methods
Media, enzymes and chemicals
For drug selections, LB plates or liquid media were supplemented with
either kanamycin (50 µg/ml), ampicillin (100 µg/ml) or spectinomycin
(50 µg/ml). When necessary, isopropyl β-D-thiogalactoside (IPTG) was
added to a final concentration of 0.3 mM and X-gal was used at
80 µg/ml. Yeast growth media and plates were made as described
[23]. Restriction endonucleases, large (Klenow) fragment of E. coli
DNA polymerase I, T4 polynucleotide kinase, T4 DNA polymerase, T4
DNA ligase were purchased from New England Biolabs. Drugs were
purchased from Sigma if not specified. 
Bacterial and yeast strains 
E. coli BW23474 [∆lac-169, rpoS(am), robA1, creC510, hsdR514,
uidA(∆MluI)::pir-116, endA, recA1] and BW23473[∆lac-169, robA1,
creC510, hsdR514, uidA(∆MluI)::pir+, endA, recA1] [24] were a gift
of B. Wanner and were used as hosts for propagation of all univector
based plasmids. CX1 (slyD) was used for propagation of E expressing
plasmids [14]. JM107 or DH5α was used as recipient host for UPS
reactions. BUN10 [hisG4 thr-1 leuB6 t lacY1 kdgK51 ∆(gpt-proA)62
rpsL31 tsx33 supE44 recB21 recC22 sbcA23 hsdR::cat-pir-
116(CmR)] was used for homologous recombination experiments.
BUN13, which has cre under the control of the lac promoter, is JM107
lysogenized with λLC (aadA lac-cre). BUN15 is XL1 blue containing
pML66 (tac-R, SpR) and was used for the in vivo R recombination
assays. E. coli BL21 was used for bacterial expression studies. S.
cerevisiae Y80 [25] was used for yeast expression studies and Hi5
cells were used for baculovirus expression. Y543 (as Y80 but cdc4-1)
was used for cdc4 suppression [22].
Construction of BUN13
The pSE356 plasmid (S.J.E., unpublished) contains a cassette consist-
ing of the Tn5 neo gene, the lac promoter and a polylinker sequence
surrounded by λ DNA sequence. The pQL114 plasmid was con-
structed in two steps. First, the BamHI–HindIII (blunt-ended) fragment
containing aadA (SpR) from pDPT270 [26] was subcloned into
BamHI–Sph I (blunt-ended) pSE356 to create pQL102, replacing neo
with aadA. Then a PCR-amplified cre gene (5′-GCGGCCGCTGAGT-
GTTAAATGTCCAATT-3′ and 5′-CCCGGGCTAATCGCCATCTTCC-
AGC-3′) was cloned into pCRTMII (Invitrogen) and subcloned as a
NotI–EcoRI fragment into pQL102, placing cre under lac control adja-
cent to aadA and flanked by λ DNA. The λKC phage [21] was amplified
on JM107 containing pQL114 and the resulting phage lysate contain-
ing the desired recombinant λLC phage was used to infect JM107. SpR
KnS lysogens were selected and a strain positive for cre expression
and the ability to perform UPS was named BUN13.
Plasmid construction
The cre gene was amplified by PCR to place an NcoI site at the first
ATG using primers 5′-CCATGGCCAATTTACTGACCGTACAC-3′
and 5′-CCCGGGCTAATCGCCATCTTCCAGC-3′. The PCR product
was cloned into pCRTMII and subcloned into pGEX-2Tkcs (W.J.
Harper, unpublished) as an NcoI–EcoRI fragment to create pQL123.
The pHOST plasmid pQL103 was made by deleting one of two loxP
sites from pSE1086 (S.J.E., unpublished) between NotI and SalI. The
590 bp NcoI–BamHI SKP1 ORF was subcloned from pCB149 [11]
into NcoI–BamHI-cleaved pUNI10 to create pQL130 (pUNI10-SKP1)
The pUNI-RAD53 (pQL135) clone was constructed by subcloning the
HA3–RAD53 gene as an NcoI–NotI (blunt-ended) fragment from
pQL49 into NcoI–BamHI (blunt-ended) pUNI10. The MYC3–RNR4
gene was subcloned from pMH176 [27] into pUNI10 to create
pQL248, or into pBAD104 (B. Desaney, unpublished) to create the
control GAL:MYC3–RNR4 plasmid pQL222. The pQL138 and
pQL193 plasmids were derived from pBAD104 by insertion of
oligonucleotide linkers containing loxP (5′-TCGAGACGTCAT-
AACTTCGTATAGCATACATTATACGAAGTTATGC-3′ and 5′-GCC-
GCATAACTTCGTATAATGTATGCTATACGATGTTATGACGTC-3′ or
loxH (5′-CATGGCTATAACTTCGTATAGCATACATTATACGAAGTT-
ATG-3′ and 5′-GATCCATAACTTCGTATAATGTATGCTATACGAAG-
TTATAGC-3′), respectively. Two GAL:MYC3–RNR4 constructs were
made by UPS using pQL248 with pQL138 or pQL193. The construc-
tion details of pHB2-GST, pHY314-MYC3, pHY326, pHI100-GST,
pHI100-MYC3, pHI100-HA3 and pHM200-HA3 are available upon
request. The pQL269 plasmid (lac–cre, SpR and oriTs) was con-
structed by ligating the EcoRI–PvuII fragment from pQL114, contain-
ing aadA (conferring spectinomycin resistance) and the lac–cre
chimeric gene, to a BglI(blunt)–EcoRI fragment containing the temper-
ature-senstive replication origin from pINT-ts [28]. The pML66 was
constructed by ligating the EcoRI–SalI (blunt-ended) fragment contain-
ing the tac promoter driving the R recombinase from pNN115 [13] to
EcoRI–PstI (blunt-ended) cleaved pQL269. The pML73 plasmid, the
pUNI20-SKP1 clone used for POT, contains the full-length SKP1 ORF
plus additional 800 bp 3′ flanking genomic sequence. The pAS2-E
plasmid (pML71) was constructed by first inserting a loxP site
between the NcoI and SalI sites of pAS2 [15] followed by a three-way
ligation using a XhoI–SpeI fragment containing tac-E, a SpeI–PstI syn-
thetic RS oligonucleotide linker, and SalI–PstI linearized pAS2-lox. The
pML74 plasmid was made by first replacing the neo gene on pUNI20
with the bla gene from pUC19 and subsequently inserting the MYC3
tag that was PCR amplified from pJBN48 (J. Bechant, unpublished;
details upon request). The PCR primers used to amplify MYC3 from
pML74 for the 3′ tagging of SKP1 were primer A (MZL179) 5′-CC-
AGAGGAGGAGGCTGCCATTAGGCGTGAAAATGAATGGGCTGA
AGACCGTTCTGAGCAAAAGCTCATTTC-3′ and primer B (MZL161)
5′-GGATATAGTTCCTCCTTTCAGC-3′.
Expression and purification of the GST–Cre fusion protein
E.coli BL21 cells containing pQL123 were grown at 37°C in LB con-
taining ampicillin to an OD600 of 0.4. IPTG was then added and the
culture was incubated at 25°C overnight. The GST–Cre fusion protein
was purified using glutathione–Sepharose beads (Pharmacia) accord-
ing to the manufacturer’s instructions. Purified GST–Cre can be
stored at –80°C, –20°C or 4°C for several months without significant
loss of activity.
In vitro UPS and POT assays
For UPS assays shown in Figure 1c, 0.4 µg DNA of each of pUNI10
and pQL103 were mixed with purified GST–Cre in a total volume of
20 µl in 1 × buffer S (50 mM Tris HCl (pH 7.5); 10 mM MgCl2, 30 mM
NaCl, 0.1 mg/ml BSA). The reaction mixtures were assembled on ice
and incubated at 37°C for 20 min followed by incubation at 65°C for
5 min to inactivate GST–Cre. Typically half of the reaction mixture was
transformed into DH5α or JM107 cells, and the transformants were
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selected on LB plates containing either ampicillin or kanamycin. For
POT assays, BUN15 cells were grown overnight in LB containing
spectinomycin, diluted to 1 in 100 in fresh LB containing spectino-
mycin and IPTG and grown to OD600 of 0.5 at 30°C, and electrocom-
petent cells were prepared as recommended (BioRad). In each
transformation, 40µl competent cells were used, and after the electro-
poration cells were incubated in LB containing IPTG for 1–4 h at 42°C
before being plated on LB/Amp/IPTG (1 mM) at 42°C.
In vivo UPS assays
BUN13 electrocompetent cells were prepared in LB containing 2%
glucose and 1 µg of each plasmid was used for electroporation followed
by incubation with LB (0.5% glucose) media at 37oC for 1 h. The trans-
formants were plated at different dilutions onto LB (0.5% glucose) plates
containing either ampicillin or kanamycin. BUN14 cells were grown in LB
media to OD600 of 0.5 at 42°C and competent cells were made as
described for BUN15. After electroporation, cells were incubated with
1 ml LB (0.5% glucose) for 1 h at 42°C before being plated onto
LB/Amp or LB/Kan plates containing 0.5% glucose at 42°C. 
β-galactosidase assays 
Yeast cells expressing GAL1:lacZ reporter constructs were grown at
30°C to mid-log phase (OD600 = 0.5–0.6) in SC-Ura media containing
2% raffinose; galactose was added to 2% final concentration and cells
were incubated at 30°C for 2 h. β-galactosidase activities were mea-
sured as previously described [25]. 
Supplementary material
A figure showing the PCR analysis of pre-UPS and post-UPS libraries
is published with this paper on the internet.
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Examination of the library representation of pre-UPS and post-UPS libraries by PCR: 42 pairs of primers were used to amplify 42 different ORFs (in
some cases only portions of ORFs were amplified) from both the pre-UPS and post-UPS libraries. For each ORF, the PCR products for the two
libraries were loaded in adjacent lanes.
